Clinical Trial Update: FASENRA SCEI for Long-term Use

View source ↗

Summary

A completed long-term extension study update for Fasenra (benralizumab) in asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• FASENRA (BENRALIZUMAB)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Status: COMPLETED